Search results
Results from the WOW.Com Content Network
Haruko Obokata (小保方 晴子, Obokata Haruko, born 1983) is a former stem-cell biologist and research unit leader at Japan's Laboratory for Cellular Reprogramming, Riken Center for Developmental Biology.
Masayo Takahashi (高橋 政代, Takahashi Masayo, born June 23, 1961) is a Japanese medical physician, ophthalmologist and stem cell researcher.. Takahashi serves as a project research leader at the Riken Center for Developmental Biology in Kobe focusing on the clinical application of iPS Cell (induced Pluripotent Stem Cell) technology on macular degeneration.
This is a list of countries by stem cell research trials for the purpose of commercializing treatments as of June 2020, using data from ClinicalTrials.gov. [ 1 ] Rank
[103] [104] By 2016, research indicated that there were more than 550 stem cell clinics in the US alone selling generally unproven therapies for a wide array of medical conditions in almost every state in the country, [105] altering the dynamic of stem cell tourism. In 2018, the FDA sent a warning letter to StemGenex Biologic Laboratories in ...
Yoshiki Sasai (笹井 芳樹, Sasai Yoshiki, 5 March 1962 – 5 August 2014) was a Japanese stem cell biologist.He developed methods to guide human embryonic stem cells (hESCs) into forming brain cortex, eyes (optic cups), and other organs in tissue culture.
National Cardiovascular Center. [1] Research Institute, National Rehabilitation Center for Persons with Disabilities. [1] International Medical Center of Japan. [1] National Institute of Health Sciences. [1] Geographical Survey Institute of Japan (Geography & Crustal Dynamics Research Center). [1] National Institute of Population and Social ...
Akita University Hospital (Japanese Wikipedia) - Akita, Akita; Akita Cerebrospinal and Cardiovascular Center (Japanese Wikipedia) - Akita, Akita; Nakadori General Hospital (Japanese Wikipedia) - Akita, Akita; Hiraka General Hospital - Yokote, Akita; Japan Community Health care Organization Akita Hospital - Noshiro, Akita
Stem cell "therapy" is an aspirational goal, is still under development and although there is a great deal of research around the world. [11] Rigorous stem cell trials are still ongoing and patients should be educated to be aware of the unethical clinics in the US or abroad, that offer stem cells procedures as a cure when it is still under ...